Acquisitions - Narrative (Details) - BioDiscovery - USD ($) $ in Thousands, shares in Millions	1 Months Ended	3 Months Ended	6 Months Ended
Oct. 31, 2021	Mar. 31, 2022	Jun. 30, 2022
Business Acquisition [Line Items]
Cash consideration transferred in acquisition	$ 52,291
Consideration transferred, common stock (in shares)	40.0
Milestone payment payable	$ 10,000
Value of shares subject to vesting	$ 26,000
Increase in acquired contract liabilities		$ 94
Intangible assets useful life			5 years

Business Acquisition, Consideration Transferred, Value Of Shares, Subject To Vesting

No definition available.

Name:	bngo_BusinessAcquisitionConsiderationTransferredValueOfSharesSubjectToVesting
Namespace Prefix:	bngo_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Business Acquisition, Milestone Payment Payable

+ References

No definition available.

+ Details

Name:	bngo_BusinessAcquisitionMilestonePaymentPayable
Namespace Prefix:	bngo_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Business Combination, Consideration Transferred, Shares

+ References

No definition available.

+ Details

Name:	bngo_BusinessCombinationConsiderationTransferredShares
Namespace Prefix:	bngo_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Contract Liability, Increase (Decrease) in Fair Value

+ References

No definition available.

+ Details

Name:	bngo_BusinessCombinationRecognizedIdentifiableAssetAcquiredAndLiabilityAssumedContractLiabilityIncreaseDecreaseInFairValue
Namespace Prefix:	bngo_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (a)(3)
-URI https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275

+ Details

Name:	us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
Namespace Prefix:	us-gaap_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_BusinessAcquisitionLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (b)(1)
-URI https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 13
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585

+ Details

Name:	us-gaap_PaymentsToAcquireBusinessesGross
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Details

Name:	us-gaap_BusinessAcquisitionAxis=bngo_BioDiscoveryMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: